Prof. Allan Doctor
Professor of Pediatrics and Bioengineering, University of Maryland School of Medicine (UMSOM)
Talk Title: “Bio-Synthetic Whole Blood Analogue: Performance Evaluation in Models of Shock and Massive Transfusion”
Allan Doctor, MD is Professor of Pediatrics and Bioengineering at the University of Maryland School of Medicine (UMSOM). He is a Pediatric Intensivist and previously led Pediatric Critical Care at Washington University and St Louis Children’s Hospital for 10 years, before transitioning to UMSOM to focus on a rapidly expanding research program and on development of a novel bio-synthetic artificial red cell (ErythroMer). He is a co-Founder and Chief Scientific officer for KaloCyte, which is developing ErythroMer for commercial use. His laboratory studies the role of red blood cell-based signaling in the control of regional blood flow, related pathophysiology arising from acquired red cell injuries, blood substitute design, and on translational transfusion medicine in critical illness.
Dr. Doctor has led two translational research networks: NIH/NICHD Collaborative Pediatric Critical Care Research Network and BloodNet, an international group that pursues questions common to Transfusion & Critical Care Medicine. Currently, he directs the University of Maryland Center for Blood Oxygen Transport and Hemostasis (CBOTH), which addresses fundamental, challenging questions related to O2 transport and hemostasis from a systems perspective, and is the Principle Investigator for CONCERT: the US DoD/DARPA funded Consortium for Optimized Integration of Bio-artificial Blood Components for Adaptive Resuscitation.
